Erich A. Fritz
Known title: EVP-Chief Supply Chain OfficerCIK: 0001769912
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
BGS Featured in Rising Junk Bond Yield Pressure Zone and Safe‑and‑Steady List. BGS was listed among ten stocks in a pressure zone as junk bond yields climb above 15%. The same company was also named a safe‑and‑steady pick in a separate analysis. The two reports suggest that while market conditions are tightening, BGS is still viewed as a stable option. Investors may note the contrast between the pressure signal and the steady rating.
Transaction History
| NATR | ▲ Buy | Grant | 9,226 | $0 | 5/15/2026 | View on chart |
| NATR | ▲ Buy | Option Exercise | 1,372 | $0 | 5/5/2026 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 469 | $12K | 5/5/2026 | View on chart |
| NATR | ▼ Sell | Other | 8,180 | — | 3/6/2026 | View on chart |
| NATR | ▲ Buy | Grant | 8,180 | $205K | 3/6/2026 | View on chart |
| NATR | ▲ Buy | Grant | 10,760 | $225K | 12/8/2025 | View on chart |
| BGS | ▼ Sell | Tax Withholding | 1,006 | $28K | 3/25/2022 | View on chart |
| BGS | ▲ Buy | Grant | 3,030 | $0 | 3/25/2022 | View on chart |
| BGS | ▲ Buy | Grant | 26,526 | $0 | 2/28/2022 | View on chart |
| BGS | ▼ Sell | Tax Withholding | 9,212 | $273K | 2/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nature's Sunshine Q2 Earnings Reviewed Against Peers
A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.
Nature's Sunshine Q2 Earnings Reviewed Against Peers. A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.